MedTrace Logo

D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure

NCT04938479 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-05-10

No results posted yet for this study

Summary

Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate.

The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score

Conditions

  • Cerebral Infarction
  • Cerebral Infarction Recovery

Interventions

BIOLOGICAL

blood sample

D-dimer measurement in blood sample

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04938479 on ClinicalTrials.gov